DNAnexus: Thomas Laur, Richard Daly
DNAnexus has named Thomas Laur as CEO and a member of the board of directors. He succeeds Richard Daly, who had led the genomic analysis software firm since 2013. Daly remains on the board and will continue to serve as an active advisor, the company said. Laur has more than 25 years of experience in healthcare software and technology services, most recently as executive VP and president of the technology-enabled services division at Change Healthcare, which merged with UnitedHealth Group's Optum a year ago. Previously, he was president of SAP's healthcare division.